Friday, June 12, 2026

How Celltrion Plans to Cut Biologics Development Costs by 25% Amid FDA Regulation Changes

Celltrion is optimistic about enhanced competitiveness due to eased biosimilar regulations by the FDA, expecting significant cost reductions.

SK Bioscience Pours 4 Billion KRW into RSM01, Accelerating RSV Antibody Trials

SK Bioscience secures funding from the Light Foundation to support clinical trials for its RSV prevention monoclonal antibody RSM01.

HD Hyundai and ABS Partner to Develop Nuclear Electric Propulsion for Container Ships

HD Hyundai partners with ABS to develop nuclear-integrated electric propulsion for zero-carbon ships, enhancing safety and efficiency.

Tag: AMIPHARM

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

New Fat Reduction Injection Shows 73.7% Success in Phase 3 Trial

AMIPHARM reveals promising phase 3 results for AYP-101, a fat reduction injection, at IMCAS 2026, targeting submental fat safely.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.